• 15141 Citations
  • 66 h-Index
1990 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andres Ferreri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Methotrexate Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

  • 15141 Citations
  • 66 h-Index
  • 341 Article
  • 3 Chapter
  • 2 Review article

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

on behalf of the “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Virus Diseases
Hepacivirus
Multicenter Studies
Lymphoma

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167

Research output: Contribution to journalArticle

Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma

Citterio, G., Calimeri, T. & Ferreri, AJM., 2018, In : Expert Review of Neurotherapeutics. 18, 5, p. 379-393 15 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Therapeutics
Combination Drug Therapy
PubMed

Clarithromycin as a "repurposing drug" against MALT lymphoma

Ferreri, AJM., Cecchetti, C., Kiesewetter, B., Sassone, M., Calimeri, T., Perrone, S., Ponzoni, M. & Raderer, M., 2018, In : British Journal of Haematology. 182, 6, p. 913-915 3 p.

Research output: Contribution to journalArticle

Drug Repositioning
Marginal Zone B-Cell Lymphoma
Clarithromycin

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, GC., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, KL. & 16 others, Hsi, ED., Choi, WWL., van Krieken, JH., Huh, J., Ponzoni, M., Ferreri, AJM., Møller, MB., Parsons, BM., Winter, JN., Piris, MA., Li, S., Miranda, RN., Medeiros, LJ., Li, Y., Xu-Monette, ZY. & Young, KH., 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Sequence Deletion
Survival
PTEN Phosphohydrolase
Messenger RNA